0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»êÈ­Áú¼Ò ÇÕ¼ºÈ¿¼Ò ¾ïÁ¦Á¦°¡ ÀÏÃø¼º ¸»ÃÊ½Å°æ ¼Õ»ó¿¡ ÀÇÇØ À¯¹ßµÈ ½Å°æº´Áõ¼º ÅëÁõ ÁãÀÇ µÞ´Ù¸®±Ù¿¡ ¹ÌÄ¡´Â ¿µÇâ

Effects of Nitric Oxide Synthase Inhibitor on Hindlimb Muscles in Rats with Neuropathic Pain Induced by Unilateral Peripheral Nerve Injury

Journal of Korean Academy of Nursing 2011³â 41±Ç 4È£ p.520 ~ 527
KMID : 0806120110410040520
ÃÖ¸í¾Ö ( Choe Myoung-Ae ) - ¼­¿ï´ëÇб³ °£È£´ëÇÐ

¾È°æÁÖ ( An Gyeong-Ju ) - Ã»ÁÖ´ëÇб³ °£È£Çаú

Abstract

Purpose:The purpose of this study was to examine effects of nitric oxide synthase (NOS) inhibitor on muscle weight and myofibrillar protein content of affected and unaffected hindlimb muscles in rats with neuropathic pain induced by unilateral peripheral nerve injury.

Methods:Neuropathic pain was induced by ligation and cutting of the left L5 spinal nerve. Adult male Sprague-Dawley rats were randomly assigned to one of two groups: The NOSI group (n=19) had NOS inhibitor (L-NAME) injections daily for 14 days, and the Vehicle group (n=20) had vehicle injections daily for 14 days. Withdrawal threshold, body weight, food intake and activity were measured every day. At 15 days all rats were anesthetized and soleus, plantaris and gastrocnemius muscles were dissected from hindlimbs. Muscle weight and myofibrillar protein content of the dissected muscles were determined.

Results:The NOSI group showed significant increases as compared to the Vehicle group for body weight at 15 days, muscle weight and myofibrillar protein content of the unaffected soleus and gastrocnemius. The NOSI group demonstrated a higher pain threshold than the vehicle group.

Conclusion:NOSI for 14 days attenuates unaffected soleus and gastrocnemius muscle atrophy in neuropathic pain model.
KeyWords
ÅëÁõ, NOS ¾ïÁ¦Á¦, ±ÙÀ§Ãà, ±ÙÀ° ´Ü¹éÁú
Pain, Nitric oxide synthase inhibitor, Muscular atrophy, Muscle proteins
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed